Accumetrics, Inc. announces the appointment of William H. Dippel to the position of Executive Vice President of Operations and R&D. Mr. Dippel will oversee the Operations, Research and Product Development departments at Accumetrics.

"We are excited to have Bill join our team," said Timothy Still, President and Chief Executive Officer of Accumetrics. "Bill's 33 years of operations and R&D experience in the healthcare industry will be a tremendous asset to Accumetrics."

Prior to joining Accumetrics, Mr. Dippel was Vice President of Operations at Barrx Medical, Inc. Before joining Barrx, Mr. Dippel was Executive Vice President of HemoSense, Inc., responsible for R&D, Manufacturing, Engineering, Materials, and Facilities Management. He provided strong leadership introducing lean manufacturing resulting in improvements in gross margin, and later played a key role during the acquisition of HemoSense by Inverness Medical Innovations.

Prior to that position, Mr. Dippel was Vice President of Operations for Micro Therapeutics -- eV3. Earlier in his career, Mr. Dippel was with Conceptus, Inc. as Vice President of R&D and Operations, and PercuSurge (now a division of Medtronic, Inc.) as Vice President of Operations and held senior positions with Boehringer Mannheim GmbH (now Roche Diagnostics), Ciba Corning Diagnostic Corporation and Spectrum Technology, Inc.

Mr. Dippel holds a B.S. in Mechanical Engineering from the California State Polytechnic University, Pomona, California.

About Accumetrics

Accumetrics is committed to advancing medical understanding of the platelet function and enhancing the quality of care for patients receiving antiplatelet therapies by providing industry-leading and widely accessible diagnostic tests for rapid platelet function assessment.